Nektar Therapeutics

0UNL•London Stock Exchange

United Kingdom

Need professional-grade analysis? Visit stockanalysis.com

£97.53

+13.48%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	26.94	—	—	—	—	26.94
Calmar	—	69.50	—	—	—	—	69.50
Sharpe	—	12.43	—	—	—	—	12.43
Omega	—	2.36	—	—	—	—	2.36
Ulcer	0.00	3.08	—	—	—	—	2.05

Also Listed On

NKTR.US

United States · USD

$2.07B

Nektar Therapeutics (0UNL) Price Performance

Nektar Therapeutics (0UNL) trades on London Stock Exchange in GBP. The stock currently trades at GBP97.53, up 13.48% from the previous close.

Over the past year, 0UNL has traded between a low of GBP36.86 and a high of GBP97.53. The stock has gained 157.4% over this period. It is currently 164.6% above its 52-week low.

Company Info

Sector: N/A
Industry: N/A
Exchange: London Stock Exchange
Currency: GBP
Country: United Kingdom

Financial Metrics

Revenue (TTM): $55.23M
EBITDA: $-129,745,000
Profit Margin: -297.07%
EPS (TTM): N/A
Book Value: 4.41

Technical Indicators

52 Week High: £106.00
52 Week Low: £28.70
50 Day MA: N/A
200 Day MA: N/A
Beta: 1.18

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: 19.50
Enterprise Value: $2.37B